Oncotarget published this trending paper on March 30, 2021, entitled, “Differential expression of Vitamin D binding protein in thyroid cancer health disparities,” researchers from Harbor-UCLA Medical Center, Loma Linda University School of Medicine, and Riverside University Health System compared the expression of DBP in patients with thyroid cancer from Filipino Americans and European Americans.
Filipino Americans are disproportionately affected by thyroid cancer, and the goal of this research was to further elucidate the functional implications of DBP in different stages of thyroid cancer across ethnicities.
“Although DBP is an essential protein with multifunctional properties, very few studies are available on its contribution to thyroid cancer oncogenesis.”
Read the full study: https://www.oncotarget.com/article/27920/text/
The Trending with Impact series highlights Oncotarget publications attracting higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels.
More from the Trending with Impact series:
https://www.oncotarget.org/tag/trending-with-impact/
Sign up for free Altmetric alerts about this article:
DOI: https://doi.org/10.18632/oncotarget.27920
Full text: https://www.oncotarget.com/article/27920/text/
Correspondence to: Salma Khan - salmakhan@llu.edu
About Oncotarget:
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
YouTube - https://www.youtube.com/c/OncotargetYouTube/
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957
Oncotarget